Skip to content

MAP-AD Test Software - Frontend

by ADmit Therapeutics Spain EUDAMED

Ref AD002

EMDN W02050192

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number8437026887AD002YK Basic UDI-DIDate21 Oct 2025RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Not covered

European Union — CE/IVDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Device Name
MAP-AD Test Software
Model / Reference
AD002
Primary DI / UDI-DI
08437026887100, 08437026887124, 08437026887117
Basic UDI-DI
8437026887AD002YK
Direct Marketing DI
08437026887100
08437026887124
08437026887117
EMDN Code
W02050192 Nucleic acid testing instruments except micro-arrays - IVD medical device software
Device Class
Class C
Special Device Type
Software
Market of Registration
Spain

Manufacturer details

EUDAMED SRN
ES-MF-000042518

Other devices from ADmit Therapeutics

Properties & raw data

Show properties, registry sources and raw records
  • Professional Testing
  • New Device
Other properties (9)
  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Reagent: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No

Sources (3)

  • EUDAMED 9c1050b9-7ffd-4e29-b969-5a7b896d8e76 61 fields · synced 22 Oct 2026
  • EUDAMED 08437026887124|8437026887AD002YK 61 fields · synced 19 May 2026
  • EUDAMED 08437026887117|8437026887AD002YK 61 fields · synced 19 May 2026